Cell No. : Cell Name
RCB1935 : HPB-ALL
update : 2024/01/17
|
Comment | Human cell line derived from T cell leukemia. TKG0199 (Deposited from Tohoku Univ.). |
Comment from the depositor | |
Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
Remarks | |
Order Form |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Depositor |
Obinata, Masuo
|
Year of deposit |
2004
|
Original cell |
TKG0199
|
Animal |
_human
< Mammals
|
Genus |
Homo
|
Species |
sapiens
|
Race |
Japanese
|
Gender |
Male
|
Tissue |
blood
|
Disease name |
T cell leukemia
|
Classification |
cancer
|
History |
Cell Resource Center for Biomedical Research, Tohoku University(TKG0199)
|
|
Lifespan |
infinite
|
Morphology |
lymphocyte-like
|
Cellosaurus(Expasy) |
CVCL_1820
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Suspension cells
|
Culture method |
|
浮遊細胞の培養に関する一般的な注意(Japanese)
|
Culture medium |
|
RPMI1640 + 10% FBS
|
Antibiotics |
|
Free
|
|
Passage method |
|
dilution
|
Culture information
|
Passage ratio |
|
1 : 10 split
|
SC frequency |
|
Subculture : 2 times/week
|
Temperature |
|
37
℃
|
CO2 concentration |
|
5
%
|
Freeze medium |
|
Medium + 10% DMSO
|
Freezing method |
|
Slow freezing
|
Mycoplasma/Acholeplasma |
|
(-)
|
Virus (HIV) |
|
LT 400
|
Virus (HTLV-1) |
|
(-)
|
Isozyme |
|
LD, NP
|
STR(human) |
|
OK
|
Reference information |
Reference |
2
|
User's Publication |
7
|
User's Publication |
21826
Terasaki T, Semba Y, Sasaki K, Imanaga H, Setoguchi K, Yamauchi T, Hirabayashi S, Nakao F, Akahane K, Inukai T, Sanda T, Akashi K, Maeda T.
The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells.
Leukemia
2024
PubMed ID: 38987275
DOI: 10.1038/s41375-024-02343-2
|
20393
Makita Y, Saito S, Tsuchiya A, Ishibashi M, Arai MA.
Identification of 1β,2α-epoxytagitinin C as a Notch inhibitor, oxidative stress mechanism and its anti-leukemia activity.
J Nat Med
2022
PubMed ID: 34779991
DOI: 10.1007/s11418-021-01584-0
|
13112
Tsuchiya A, Makita Y, Koyano T, Kowithayakorn T, Ishibashi M, Arai MA.
Isolation and evaluation of cardenolides from Lansium domesticum as Notch inhibitors.
J Nat Med
2020
PubMed ID: 32648094
DOI: 10.1007/s11418-020-01432-7
|
10804
Arai MA, Akamine R, Tsuchiya A, Yoneyama T, Koyano T, Kowithayakorn T, Ishibashi M.
The Notch inhibitor cowanin accelerates nicastrin degradation.
Sci Rep
2018
8:5376
PubMed ID: 29599482
DOI: 10.1038/s41598-018-23698-4
|
9651
Randhawa S, Cho BS, Ghosh D, Sivina M, Koehrer S, Müschen M, Peled A, Davis RE, Konopleva M, Burger JA.
Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemia.
Br. J. Haematol.
2016
174:425-36
PubMed ID: 27071778
DOI: 10.1111/bjh.14075
|
5608
Zhou X, Koizumi Y, Zhang M, Natsui M, Koyota S, Yamada M, Kondo Y, Hamada F, Sugiyama T.
Cadmium-coordinated supramolecule suppresses tumor growth of T-cell leukemia in mice
Cancer Sci
2015
106(5):635-41
PubMed ID: 25735932
DOI: 10.1111/cas.12651
|
16810
Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, Kurokawa M, Chiba S, Bailey DK, Kennedy GC, Ogawa S.
A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays
Cancer Res
2005
65(14):6071-9
PubMed ID: 16024607
DOI: 10.1158/0008-5472.CAN-05-0465
|